About Cadrenal Therapeutics Inc
- Industry: Pharmaceuticals
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.cadrenal.com/
Frequently Asked Questions
What is the 52-week range for CVKD?
The 52-week high is $14.6399 and the 52-week low is $0.97.
What is the P/E ratio for CVKD?
The P/E ratio data is currently unavailable.
What is the dividend yield for CVKD?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -406.38%.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 5.79.
Analyst Recommendation Trends
Wall Street analyst consensus for CVKD over the last few months:
Latest CVKD News
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2026 Investor Conference
PONTE VEDRA, Fla., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing specialized therapies for critical care cardiology and orphan cardiovascular conditions, announced that CEO Quang X. Pham will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2026 Investor Conference, taking place virtually on September 29-30, 2026. Company Webcast The webcast presentation
Cadrenal Therapeutics to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
PONTE VEDRA, Fla., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company advancing specialized therapies for critical care cardiology and orphan cardiovascular conditions, announced that CEO Quang X. Pham will participate in the 28th Annual H.C. Wainwright Global Investment Conference, September 14–16, 2026, at the Lotte New York Palace Hotel in New York City. A pre-recorded presentation from the Company will be available on demand
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-06-29 | Pham Quang X | -7,400 | $3.03 | $22,422 |
| 2026-06-26 | Pham Quang X | -9,029 | $3.05 | $27,538 |
| 2026-06-25 | Pham Quang X | -2,127 | $3 | $6,381 |
| 2026-06-23 | Pham Quang X | -2,277 | $3.2 | $7,286 |
| 2026-06-22 | Pham Quang X | -9,167 | $3.55 | $32,543 |
| 2026-06-17 | Pham Quang X | -513 | $3.16 | $1,621 |
| 2026-06-16 | Pham Quang X | -3,613 | $3.18 | $11,489 |
| 2026-06-15 | Pham Quang X | -3,666 | $3.58 | $13,124 |
| 2026-06-12 | Pham Quang X | -12,996 | $3.94 | $51,204 |
| 2026-06-11 | Pham Quang X | -1,462 | $4.12 | $6,023 |
| 2026-06-10 | Pham Quang X | -3,500 | $4.21 | $14,735 |
| 2026-06-09 | Pham Quang X | -12,992 | $4.06 | $52,748 |
| 2026-06-08 | Pham Quang X | -5,893 | $4.38 | $25,811 |
| 2026-06-05 | Pham Quang X | -2,064 | $4.42 | $9,123 |
| 2026-06-04 | Pham Quang X | -3,898 | $4.41 | $17,190 |
| 2026-06-03 | Pham Quang X | -2,323 | $4.26 | $9,896 |
| 2026-06-02 | Pham Quang X | -349 | $4.46 | $1,557 |
| 2026-05-29 | Pham Quang X | -303 | $5.01 | $1,518 |
| 2026-05-28 | Pham Quang X | -2,989 | $4.93 | $14,736 |
| 2026-05-22 | Pham Quang X | -1,165 | $5.69 | $6,629 |
| 2026-05-12 | Pham Quang X | -3,298 | $5.28 | $17,413 |
| 2026-05-11 | Pham Quang X | -6,476 | $5.76 | $37,302 |
| 2025-12-29 | Szot Matthew K | -9,933 | $6.97 | $69,233 |
| 2025-12-02 | Golden Lee Scott | +5,000 | - | - |
| 2025-10-27 | Pham Quang X | -1,315 | $13.99 | $18,397 |
| 2025-10-27 | Szot Matthew K | -1,800 | $13.99 | $25,182 |
| 2025-10-24 | Pham Quang X | -1,129 | $14.03 | $15,840 |
| 2025-10-24 | Szot Matthew K | -1,800 | $13.99 | $25,182 |
| 2025-10-13 | Pham Quang X | -1,800 | $14.15 | $25,470 |
| 2025-10-13 | Szot Matthew K | -1,800 | $14.07 | $25,326 |
| 2025-10-09 | Pham Quang X | -1,800 | $14.02 | $25,236 |
| 2025-10-09 | Szot Matthew K | -1,693 | $13.99 | $23,685 |
| 2025-10-06 | Szot Matthew K | -107 | $13.99 | $1,497 |